Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Pickles

Showing results (81-90 of 139) with videos related to

Pageof 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 6, 2010
Evaluating the Phoenix definition of biochemical failure after (125)I prostate brachytherapy: Can PSA kinetics distinguish PSA failures from PSA bounces?Anna Thompson, Mira Keyes, Tom Pickles, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Percentage of biopsy cores positive for malignancy and biochemical failure following prostate cancer radiotherapy in 3,264 men: statistical significance without predictive performanceScott G Williams, Mark K Buyyounouski, Tom Pickles, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 19, 2012
The need for, and utilization of prostate-bed radiotherapy after radical prostatectomy for patients with prostate cancer in British ColumbiaScott Tyldesley, Michael Peacock, James W Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2013
Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survivalAndrea C Lo, W James Morris, Vincent Lapointe, et al.
Psycho-Oncology|June 27, 2009
Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional roleThomas F Hack, Tom Pickles, J Dean Ruether, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2008
Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field sizeBelinda A Campbell, Nick Voss, Tom Pickles, et al.
European Urology|February 21, 2012
Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational studyMeelan Bul, Xiaoye Zhu, Antti Rannikko, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 16, 2011
Facilitating the implementation of empirically valid interventions in psychosocial oncology and supportive careThomas F Hack, Linda Carlson, Lorna Butler, et al.
Brachytherapy|June 21, 2022
After ASCENDE-RT: Biochemical and survival outcomes following combined external beam radiotherapy and low-dose-rate brachytherapy for high-risk and unfavourable intermediate-risk prostate cancer, a population-based analysisJustin Oh, W James Morris, Ingrid Spadinger, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2006
An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer riskScott G Williams, Gillian M Duchesne, N Kumar Gogna, et al.
Pageof 14

Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|February 6, 2010
Evaluating the Phoenix definition of biochemical failure after (125)I prostate brachytherapy: Can PSA kinetics distinguish PSA failures from PSA bounces?Anna Thompson, Mira Keyes, Tom Pickles, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Percentage of biopsy cores positive for malignancy and biochemical failure following prostate cancer radiotherapy in 3,264 men: statistical significance without predictive performanceScott G Williams, Mark K Buyyounouski, Tom Pickles, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 19, 2012
The need for, and utilization of prostate-bed radiotherapy after radical prostatectomy for patients with prostate cancer in British ColumbiaScott Tyldesley, Michael Peacock, James W Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2013
Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survivalAndrea C Lo, W James Morris, Vincent Lapointe, et al.
Psycho-Oncology|June 27, 2009
Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional roleThomas F Hack, Tom Pickles, J Dean Ruether, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2008
Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field sizeBelinda A Campbell, Nick Voss, Tom Pickles, et al.
European Urology|February 21, 2012
Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational studyMeelan Bul, Xiaoye Zhu, Antti Rannikko, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 16, 2011
Facilitating the implementation of empirically valid interventions in psychosocial oncology and supportive careThomas F Hack, Linda Carlson, Lorna Butler, et al.
Brachytherapy|June 21, 2022
After ASCENDE-RT: Biochemical and survival outcomes following combined external beam radiotherapy and low-dose-rate brachytherapy for high-risk and unfavourable intermediate-risk prostate cancer, a population-based analysisJustin Oh, W James Morris, Ingrid Spadinger, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2006
An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer riskScott G Williams, Gillian M Duchesne, N Kumar Gogna, et al.
Pageof 14